Baxter International Inc. disclosed in its latest quarterly report on Form 10-Q filed with the U.S. Securities and Exchange Commission that it is fully cooperating with the request through a subpoena from the Office of the U.S. Attorney of the…
Baxter International Inc. disclosed in its latest quarterly report on Form 10-Q filed with the U.S. Securities and Exchange Commission on May 5, 2009, that the company remains a defendant, along with others, in over 50 lawsuits brought in various…
Baxter International Inc. disclosed in its latest quarterly report on Form 10-Q filed with the U.S. Securities and Exchange Commission on May 5, 2009, that discovery is still ongoing on the lawsuit filed in connection with the recall of heparin…
Baxter International Inc. disclosed in its latest quarterly report on Form 10-Q filed with the U.S. Securities and Exchange Commission on May 5, 2009, that more third party claims may be filed over the Company’s COLLEAGUE and SYNDEO infusion pumps.
On…